[Results of a clinical study of a new anxiolytic, a blocker of central cholecystokinin receptors].
Observational study · 2019
- What was studied
- 31 adults with generalized anxiety disorder
- Main finding
- A 31-person, 21-day uncontrolled GB-115 pilot reported improvements in anxiety, attention and sleep; it does not quantify an advantage over placebo or standard drugs.
Reported findings and study design
A 31-person, 21-day uncontrolled GB-115 pilot reported improvements in anxiety, attention and sleep; it does not quantify an advantage over placebo or standard drugs.
31 adults with generalized anxiety disorder, aged 22–53: 22 women, 9 men.
Dose, route and schedule
GB-115 was studied as 1 mg tablets during 21 days of treatment. The authors identified 6 mg/day as the effective dose in this report; the abstract does not give a divided-dose schedule.
Protocol source ↗ · Indexed publication abstract
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Anxiety and cognitive measures | Reported favorable changes; no numerical scale deltas in indexed abstract | |
| Participants | 31 (22 women; 9 men) | |
| Studied dose and duration | Effective dose described as 6 mg/day; 21 days |
This pilot is distinct from the larger phase II/III reports, and possible overlap with later 25-person conference analyses remains flagged.
Source for these results ↗ · Reviewed 2026-11-01
Study limitations and source details
Study limitations
- Uncontrolled pilot evidence; expectancy and repeated-testing effects remain possible.
- Later 25-patient conference analyses may overlap and are not counted as independent replication.
Source details
Primary publication metadata and indexed abstract checked via Europe PMC; full methodological review pending.
Abstract reviewed
Sources checked
Citation
Neznamov GG, Dorofeeva OA, Metlina MV, Syunyakov TS, Minaev SV, Ivashkina NY, Martyanov VA, Seredenin SB. [Results of a clinical study of a new anxiolytic, a blocker of central cholecystokinin receptors]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Study source ↗ · DOI 10.17116/jnevro201911908153 · Bibliography entry · Link to this summary